Quick Answer
Instil Bio, Inc. reported Total Assets of $203.52 million for the year ending 2025.
- Instil Bio, Inc. showed a decrease of -22.8% in Total Assets from 2024 to 2025.
- This data is from Instil Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $696.14 million | Q2 2021: $672.67 million | Q3 2021: $647.40 million | Q1 2022: $564.94 million | Q2 2022: $568.54 million | Q3 2022: $532.74 million | Q1 2023: $427.17 million | Q2 2023: $408.31 million | Q3 2023: $340.27 million | Q1 2024: $306.30 million | Q2 2024: $294.32 million | Q3 2024: $272.56 million | Q1 2025: $237.45 million | Q2 2025: $230.99 million | Q3 2025: $211.77 million.
- Over the full 6 years of available data (2020 to 2025), Instil Bio, Inc.'s Total Assets has declined by 36.2%.
- Historical annual values: Fiscal year 2025: $203.52 million | Fiscal year 2024: $263.57 million | Fiscal year 2023: $325.63 million | Fiscal year 2022: $482.13 million | Fiscal year 2021: $609.98 million | Fiscal year 2020: $319.01 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: